Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study of MK-8527 taken once monthly compared to emtricitabine/tenofovir taken daily for HIV-1 prevention
FranceSafety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema
GermanyStudy of sublingual immunotherapy with Phleum pratense pollen extract spray in patients with moderate to severe grass pollen allergic rhinitis
GermanyStudy of CLU-RX-PHL injection therapy for patients with moderate to severe grass pollen allergy to find the most effective and safe dose
GermanyComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
AustriaStudy comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy
AustriaStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
CroatiaStudy on the Effects and Safety of Coramitug for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR CM)
CzechiaStudy on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis
DenmarkStudy on the Effects and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy
FranceStudy on the Effects of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria
BulgariaStudy of Felzartamab for Patients with Late Antibody-Mediated Rejection After Kidney Transplant
AustriaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
